2nd KEMRI Annual Scientific & Health Conference (KASH)

In order to view this object you need Flash Player 9+ support!

Get Adobe Flash player

Powered by RS Web Solutions

Saturday, July 04, 2015
Text Size

Course Announcement

In the News

Written on 28 October 2013, 09.59 by Administrator
kemri-purchases-first-aid-kits-worth-08million Director, KEMRI Prof. Solomon Mpoke receives a consignment of First Aid kits from the Kenya Red Cross, General Manager, Susan Ng'ong'a at the...
Written on 28 October 2013, 08.31 by Administrator
call-for-abstracts-4th-kemri-annual-scientific-a-health-kash-conference 4th KEMRI ANNUAL SCIENTIFIC & HEALTH (KASH) CONFERENCE CALL FOR ABSTRACTS 2ND ANNOUNCEMENT The KASH Organizing Committee is pleased to...
Written on 23 October 2013, 18.15 by Administrator
health-cabinet-secretary-graces-kemris-iso-certification-a-calls-for-more-funding-for-rad Director, KEMRI Prof. Solomon Mpoke, receives ISO 9001:2008 dummy Certificate from SGS, Head of Certification, Mr. Kioko Ndolo during...
Written on 30 September 2013, 07.55 by Administrator
kemri-wins-catalytic-mhealth-grantsThe mHealth Alliance officially announced that the Kenya Medical Research Institute, Texting to Improve Testing (TextIT) Strategy: Text messaging to ...
Written on 26 August 2013, 10.30 by Administrator
kemri-hosts-a-cbrne-commodity-identification-training-course-for-trainers-in-kenyaProf. Solomon Mpoke, Director KEMRI (right) admires the Chemical, Biological, Radiological, Nuclear and Explosive Commodity Identification Training...

Calendar of Events

July 2015 August 2015
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
There are no upcoming events to display
View Full Calendar

KEMRI Hosts Chemical, Biological and Nuclear Workshop


By: Rhoda Ityang'

The Kenya Medical Research Institute (KEMRI) hosted a four day Chemical, Biological, Radiological, Nuclear and Explosives Commodity Identification Training (CBRNe), which was held on August 4th -8th 2013 at the Training Centre. The CBRNe workshop was sponsored by the US Department of Energy and the US National Nuclear Security Administration (NASA).

Read More


KEMRI Bioethics Review Vol 3 Issue 3_Page_01

KEMRI Biotech News Vol 3 Sept 2013-final_Page_1


By Davis Mkoji


Cabinet Secretary of Health Mr. James Macharia (middle) cutting a cake to celebrate the KEMRI certification for the ISO 9001:2008 (QMS) at KEMRI Headquarters yesterday. From (left) Board Member & CEO, NACOSTI Prof. Shaukat Abdulrazak, Director, KEMRI Prof. Solomon Mpoke, Principle Secretary of Health, Prof. Fred Segor, KEMRI Chairperson Prof. Ruth Nduati, and a Board member Prof. Norah Olembo (far right) among other staff.

Read More

2nd KEMRI Annual Scientific & Health Conference (KASH)

Theme: Towards A Healthy, Globally Competitive Nation: Vision 2030 Flagships

Dr. Edwin Muinga

Dr. Edwin Muinga Chokwe, HSC,
Chairman, KEMRI Board of Management

Attaining Kenya Vision 2030, the nation's economic blueprint, requires a fresh perspective in the way we perceive research and KEMRI's role in national development. The link between health and poverty is self evident as each impacts the other resulting in a vicious cycle where poor health is both a result and a cause of poverty.

As such the dealing with one without being cognizant of the other only serves to derail the desired impact. Health research should therefore be linked to economic development through the promoting of human and social development, and also more directly through industrialization as we strive to attain a knowledge-economy driven, middle income status by the year 2030. This was reflected in the theme of this year's conference, "Towards a healthy, globally competitive nation: Vision 2030 flagships," which affirms KEMRI's role not just in human and social development but also in the knowledge economy through the innovation of R&D outputs.


Bridging the Gap in Health Research in Africa

This conference therefore serves to showcase excellence in research as the bedrock of this theme. Two major ground breaking research results emanating from research carried out by KEMRI and our collaborators have recently been listed among the top 10 technological breakthroughs of the year by the journal Science. This includes the phase III clinical trial results of the candidate malaria vaccine RTSS, which reported 56 percent and 47 percent efficacy in the prevention of clinical and severe malaria in children respectively. The multicentre trial was conducted in 11 sites across 7 African countries, in which KEMRI played a significant role, having hosted 3 of the 11 sites at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, the KEMRI-Wellcome-Trust Research Programme in Kilifi and the KEMRI/Walter Reed Project site at Kombewa.

The other major breakthrough in which KEMRI has been involved is the HIV Prevention Trials Network (HPTN) multinational clinical study, HPTN 052, which demonstrated reduction of HIV transmission in serodiscordant couples through the early treatment of HIV using ARVs by an astounding 96 percent. Both studies have served to inform policy and revitalize the fight against the scourge of these diseases not just in Kenya but the world over.

Additionally, KEMRI remains committed to the national and WHO roadmaps for the control and elimination of 10 of the 17 neglected tropical diseases by the year 2020. Significant advances have been made on this front with results emanating from DNDi, of which KEMRI is both a founding member and partner through CCR, have informed the WHO recommendation of paramomycin-sodium

 stibogluconate (PM-SSG) drug combination as the first line treatment for visceral leishmaniasis in east Africa.

Further to the excellent research coming out of KEMRI, the conference also highlighted special areas of public health interest through dedicated symposia focusing on road safety, neglected tropical diseases, bioethics, health systems and social sciences research, all addressing aspects of health and human/social development.

For the first time, a symposium on pharmaceutical and health products innovation, focusing solely on the business of the science addressed aspects of knowledge economy and industrialization.

DKDr. Solomon Mpoke, PhD, MBS,
Director, KEMRI


What's New


Director, KEMRI Prof. Solomon Mpoke receives a consignment of First Aid kits from the Kenya Red Cross, General Manager, Susan Ng'ong'a at the KEMRI Headquarters Nairobi . (Left) Mr. J. N. Kariuki, Assistant Director (Administration) and Ms. Ann Wang'ombe, Assistant Director (Human Resource) and Meshack Laanoi, Kenya Red Cross Sales Leader and a KEMRI driver, Charles Nuthu. A total of 86 First Aid Kits worth over Kshs. 800,000/- were purchased through the KEMRI Bio risk project.. The Kits will be fixed on KEMRI Research Vehicles and All KEMRI Laboratories and Research Facilities in the Country.

Read More

Coming Up



Read More . . .




We have 365 guests online


"To be a leading centre of excellence in human health research."


"To improve human health and quality of life through research, capacity building and service delivery."


"In Search of Better Health"
towards the realization of our Vision


Do you have a complaint?
Click Here